Citation: | WANG Yuxiang, TIAN Dandan, QIU Rong, TIAN Xiuming, WANG Lili. Influence Factors for Radiation Pneumonitis in Stage Ⅲ Non-small Cell Lung Cancer Patients Treated with Three-dimensional Conformal Radiotherapy[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1307-1312. DOI: 10.3971/j.issn.1000-8578.2014.12.012 |
[1] |
Rodrigues G, Lock M, D’Souza D, et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer- -a systematic review[J]. Radiother Oncol, 2004, 71(2):127-38.
|
[2] |
Kim M, LeeJ, Ha B, et al. Factors predicting radiation pneumonitis in locally advanced non-small cell lung cancer[J]. Radiat Oncol J, 20 11, 29(3): 181-90.
|
[3] |
Palma DA, Senan S, Tsujino K, et al. Predicting radiation pneumo nitis after chemoradiation therapy for lung cancer: an international individual patient data Meta-analysis[J]. Int J Radiat Oncol Biol Phys, 2013, 85(2): 444-50.
|
[4] |
Fay M, Tan A, Fisher R, et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2005, 61 (5): 1355-63.
|
[5] |
Fu HY, Lu B,Xu BQ, et al. Prospective study of lung V5 and V10 in predicting radiation-induced lung injury in advanced nonsmall- cell lung cancer treated with three-dimensional conformal radiation therapy[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 20 09, 18(6): 439-42. [付和谊, 卢冰, 徐冰清, 等. Ⅲ+Ⅳ期非小细 胞肺癌三维适形放疗正常肺V5、V10预测放射性肺损伤前瞻 性临床研究[J]. 中华放射肿瘤学杂志, 2009, 18(6): 439-42.]
|
[6] |
Wang J, Qiao XY, Cao YK, et al. Analysis of correlated factors of radiation pneumonitis after three-dimensional conformal radiotherapy for non-small cell lung cancer[J].Zhongguo Zhong Liu Lin Chuang, 2009, 36(19): 1086-9. [王静, 乔学英, 曹彦坤, 等. 非小细胞肺癌三维适形放疗放射性肺炎发生的多因素分析 [J] 中国肿瘤临床, 2009, 36(19): 1086-9.]
|
[7] |
Zhuang TT, Liu Q, Zhang L, et al. Risk factors of acute radiation pneumonitis in patients with non-small cell lung cancer after concurrent three-dimensional conformal radiotherapy and chemotherapy [J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 20 09, 18(6): 443-7. [庄婷婷, 柳青, 张黎, 等. 非小细胞肺癌三维 适形放疗同期化疗后急性放射性肺炎发生因素分析[J].中华放 射肿瘤学杂志, 2009, 18(6): 443-7.]
|
[8] |
Zhu XZ, Wang LH, Wang YJ, et al. Risk factors of radiation pneumonitis in stage III non-small cell lung cancer treated with three-dimensional conformal radiotherapy[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2007, 16(6): 421-8. [朱向帜, 王绿化, 王 颖杰, 等. 三维适形放疗局部晚期非小细胞肺癌的放射性肺炎 风险因素研究[J]. 中华放射肿瘤学杂志, 2007, 16(6): 421-8.]
|
[9] |
Wang DQ, Zhang J, Li BS, et al. Dose-volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve[J]. Zhonghua Fang She Yi Xue Yu Fang Hu Za Zhi, 2012, 32(5): 505-8. [王冬青, 张建, 李宝生, 等. 剂量体积直方图参数对放射性肺炎的工作特征曲线预测分析 [J] 中华放射医学与防护杂志, 2012, 32(5): 505-8.]
|
[10] |
Yom SS, Liao Z, Liu HH, et al. Initial evaluation of treatmentrelated pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy[J]. Int J Radiat Oncol Biol Phys, 20 07, 68(1): 94-102.
|
[11] |
Shi A, Zhu G, Wu H, et al. Analysis of clinical and dosimetric factors associated with severe acute radiationpneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy[J]. Radiat Oncol, 2010, 5: 35.
|
[12] |
Oh D, Ahn YC, Park HC, et al. Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors[J]. Jpn J Clin Oncol, 2009, 39(3): 151-7.
|
[13] |
Jin H, Tucker SL, Liu HH, et al. Dose-volume thresholds and smoking status for the risk of treatment-relatedpneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy [J]. Radiother Oncol, 2009, 91(3): 427-32.
|
[14] |
Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-relatedpneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)[J]. Int J Radiat Oncol Biol Phys, 2006, 66 (5): 1399-407.
|
[15] |
Wang J, Wang P, Pang QS, et al. Clinical and dosimetric factors associated with radiation-induced lung damage in patients with non small cell lung cancer treated with three-dimentional conformal radiotherapy[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2009, 18(6): 448-51. [王静, 王平, 庞青松, 等. 非小细胞 肺癌三维适形放疗放射性肺损伤临床及剂量学因素分析[J]. 中 华放射肿瘤学杂志, 2009, 18(6): 448-51. ]
|
[16] |
Wang J, Zhang TT, He ZC, et al. Severe acute radiation pneumonitis after concurrent chemoradiotherapy in non-small cell lung cancer[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2012, 21 (4): 326-9. [王谨, 庄婷婷, 何智纯, 等. 非小细胞肺癌同期放 化疗后重度急性放射性肺炎的预测因素[J]. 中华放射肿瘤学杂 志, 2012, 21(4): 326-9.]
|
[17] |
Wang D, Li B, Wang Z, et al. Functional dose-volume histograms for predicting radiation pneumonitis in locally advanced nonsmall cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy[J]. Exp Ther Med, 2011, 2(5): 10 17-22.
|
[18] |
Zhang XJ, Sun JG, Sun J, et al. Prediction of radiation pneumon itis in lung cancer patients: a systematic review[J]. J Cancer Res Clin Oncol, 2012, 138(12): 2103-16.
|
[19] |
Dang J, Li G, Lu X, et al. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced nonsmall- cell lung cancer treated with three-dimensional conformal radiotherapy[J]. J Cancer Res Clin Oncol, 2010, 136(8): 1169-78.
|
[20] |
Kong FM, Hayman JA, Griffith KA, et al. Final toxicity results of a radiation-dose escalation study in patients with non-smallcell lung cancer (NSCLC): predictors for radiation pneumonitis a nd fibrosis[J]. Int J Radiat Oncol Biol Phys, 2006, 65(4): 1075-86.
|
[21] |
Dang J, Li G, Ma L, et al. Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced nonsmall cell lung cancer treated with three-dimensional conformal radiotherapy [J]. Acta Oncol, 2013, 52(6): 1175-80.
|
[22] |
Parashar B, Edwards A, Mehta R, et al. Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer[J]. Am J Clin Oncol, 20 11, 34(2): 160-4.
|
[23] |
Bradley JD, Paulus R, Komaki R, et al. A randomized phase Ⅲ comparison of standard-dose(60Gy)versus highdose( 74 Gy)comformal chemoradio+/- cetuximab for stage III nonsmall cell lung cancer: results on radiation dose in RTOG 0617[J]. J Clin Oncol, 2013, 31(suppl;abstr 7501).
|
[1] | XU Yao, LIU Shiguo, ZHANG Chang, ZHANG Li, JIANG Shan, ZHANG Junxia, PENG Li. Clinical Significance of Detection of ZIC1 Promoter Methylation in Peripheral Blood and Cancer Tissues of Non-small Cell Lung Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2021, 48(4): 354-357. DOI: 10.3971/j.issn.1000-8578.2021.20.0911 |
[2] | WAN Lihui, ZHANG Na, HUANG Ying, LI Wei, WANG Liuhua, ZHENG Yuqin, SUN Zhenzhu, CAO Yuwen. Clinical Significance of JAG1 Gene Methylation in Uygur Breast Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2017, 44(11): 734-739. DOI: 10.3971/j.issn.1000-8578.2017.17.0501 |
[3] | KANG Yani, LAI Dengpan, ZHANG Xiaoli, CHEN Jian, ZHAO Xiaodong. CpG Islands Methylation Status in SHP1 Gene Promoter Region in Gastric Cancer Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(08): 871-875. DOI: 10.3971/j.issn.1000-8578.2014.08.003 |
[4] | SONG Chao, ZHANG Yun, JIN Yongtang, YU Zaicheng, XUE Shaoli. Detection and Clinical Significance of DAPK Gene Methylation in Plasma of Non-small Cell Lung Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2013, 40(08): 772-775. DOI: 10.3971/j.issn.1000-8578.2013.08.011 |
[5] | GUO Wei, GUO Yan-li, YANG Zhi-bin, KUANG Gang, QIAO Yi-ling, DONG Zhi-ming. Promoter Methylation of Transforming Growth Factor-beta Receptor Type 1 Gene and Expression of TGF-β1 in Gastric Cardia Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(05): 524-527. DOI: 10.3971/j.issn.1000-8578.2011.05.011 |
[6] | TAN Shuang-xiang, HU Rui-cheng, XIAO Zhi-qiang, TANG Can-e, YI Hong, RUAN Lin, WANG Ning, HONG Xiu-qin. Methylation of annexin A1 Gene Promotes Lymphoid Node Metastasis in Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(12): 1374-1379. DOI: 10.3971/j.issn.1000-8578.2010.12.011 |
[7] | GUO Yan-li, JIN Guo-liang, GUO Wei, KUANG Gang, YANG Zhi-bin, DONG Zhi-ming. Relationship between Promoter Methylation of Wif-1 and Protein Expression of VEGF-C/VEGF-D in Gastric Cardia Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(09): 1044-1047. DOI: 10.3971/j.issn.1000-8578.2010.09.018 |
[8] | DONG Zhi-ming, GUO Wei, HE Ming, YANG Zhi-bin, KUANG Gang, WANG Shi-jie. Expression and Methylation Status of RASSF1A Gene in Gastric Cardiac Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2009, 36(07): 566-570. DOI: 10.3971/j.issn.1000-8578.2009.07.008 |
[9] | YU Zong-tao, YUAN Ya-li, ZHANG Ji-cai, GAO Qiong, WANG Yuan-yuan. Transcriptional Expression and Promoter methylation of FHIT gene in Lung Carcinoma Tissues and Cell[J]. Cancer Research on Prevention and Treatment, 2007, 34(07): 498-500. DOI: 10.3971/j.issn.1000-8578.2226 |
[10] | LIU Fen, YU Jie-ping, DENG Quan-jun, QI Yuan-ling, YU Hong-gang. Studying the Expression of PTEN and Its CpG Island Methylation Status in Gastric Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2006, 33(09): 632-634. DOI: 10.3971/j.issn.1000-8578.1326 |